MCA
TNDM icon

Maryland Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Maryland Capital Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20
Closed -$416 – 249
2023
Q3 		$416 Hold
20
– – ﹤0.01% 234
2023
Q2 		$491 Buy
+20
New +$643 ﹤0.01% 239

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Maryland Capital Advisors's TNDM Position: Q4 2023 in Review

Maryland Capital Advisors sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 20 shares — an estimated $416 sold.

Maryland Capital Advisors first reported a position in TNDM in Q2 2023 and held it in 2 quarters. The position peaked at $491 in Q2 2023. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Maryland Capital Advisors reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Maryland Capital Advisors sold 20 Tandem Diabetes Care shares in Q4 2023, an estimated $416.
  • Maryland Capital Advisors first reported a position in Tandem Diabetes Care in Q2 2023 and held it in 2 quarters.
  • Maryland Capital Advisors's Tandem Diabetes Care position peaked at $491 in Q2 2023.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Maryland Capital Advisors's 13F filing for Q4 2023, filed 17 Jan 2024.